Cargando…
It is time to change the way we manage mild asthma: an update in GINA 2019
Asthma is a heterogeneous lung disease, usually characterised by chronic airway inflammation. Although evidence-based treatments are available in most countries, asthma control remains suboptimal, and asthma-related deaths continue to be an ongoing concern. Generally, it is believed that between 50...
Autores principales: | Muneswarao, Jaya, Hassali, Mohamed Azmi, Ibrahim, Baharudin, Saini, Bandana, Ali, Irfhan Ali Hyder, Verma, Ashutosh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694574/ https://www.ncbi.nlm.nih.gov/pubmed/31412856 http://dx.doi.org/10.1186/s12931-019-1159-y |
Ejemplares similares
-
Validation and clinical interpretation of the St George’s respiratory questionnaire for COPD (SGRQ-C) after adaptation to Malaysian language and culture, in patients with COPD
por: Rehman, Anees ur, et al.
Publicado: (2020) -
Economic Burden of Chronic Obstructive Pulmonary Disease Patients in Malaysia: A Longitudinal Study
por: ur Rehman, Anees, et al.
Publicado: (2020) -
New approach to intermittent and mild asthma therapy: evolution or revolution in the GINA guidelines?
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2020) -
Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update
por: Levy, Mark L., et al.
Publicado: (2023) -
Diagnosis and management of asthma – Statement on the 2015 GINA Guidelines
por: Horak, Fritz, et al.
Publicado: (2016)